X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs NATCO PHARMA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD NATCO PHARMA MERCK LTD/
NATCO PHARMA
 
P/E (TTM) x 48.4 16.3 296.5% View Chart
P/BV x 7.3 17.6 41.5% View Chart
Dividend Yield % 0.4 0.7 59.5%  

Financials

 MERCK LTD   NATCO PHARMA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
NATCO PHARMA
Mar-14
MERCK LTD/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,060877 120.9%   
Low Rs623424 147.1%   
Sales per share (Unadj.) Rs632.4223.4 283.1%  
Earnings per share (Unadj.) Rs45.731.1 147.2%  
Cash flow per share (Unadj.) Rs62.340.3 154.7%  
Dividends per share (Unadj.) Rs11.005.00 220.0%  
Dividend yield (eoy) %1.30.8 170.0%  
Book value per share (Unadj.) Rs388.8219.5 177.1%  
Shares outstanding (eoy) m16.6033.07 50.2%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x1.32.9 45.7%   
Avg P/E ratio x18.420.9 87.9%  
P/CF ratio (eoy) x13.516.1 83.6%  
Price / Book Value ratio x2.23.0 73.1%  
Dividend payout %24.116.1 149.5%   
Avg Mkt Cap Rs m13,96921,504 65.0%   
No. of employees `0001.6NA-   
Total wages/salary Rs m1,4871,128 131.8%   
Avg. sales/employee Rs Th6,631.9NM-  
Avg. wages/employee Rs Th939.2NM-  
Avg. net profit/employee Rs Th479.4NM-  
INCOME DATA
Net Sales Rs m10,4987,389 142.1%  
Other income Rs m242167 145.1%   
Total revenues Rs m10,7417,556 142.1%   
Gross profit Rs m1,1351,793 63.3%  
Depreciation Rs m276304 90.5%   
Interest Rs m0366 0.0%   
Profit before tax Rs m1,1021,290 85.5%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m343309 111.2%   
Profit after tax Rs m7591,027 73.9%  
Gross profit margin %10.824.3 44.6%  
Effective tax rate %31.123.9 130.1%   
Net profit margin %7.213.9 52.0%  
BALANCE SHEET DATA
Current assets Rs m6,4103,681 174.1%   
Current liabilities Rs m8,8283,123 282.7%   
Net working cap to sales %-23.07.6 -304.8%  
Current ratio x0.71.2 61.6%  
Inventory Days Days5889 64.5%  
Debtors Days Days3859 65.4%  
Net fixed assets Rs m1,4067,685 18.3%   
Share capital Rs m166331 50.2%   
"Free" reserves Rs m6,2866,670 94.2%   
Net worth Rs m6,4557,259 88.9%   
Long term debt Rs m0955 0.0%   
Total assets Rs m8,82811,957 73.8%  
Interest coverage xNM4.5-  
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.20.6 192.4%   
Return on assets %8.611.7 73.8%  
Return on equity %11.814.2 83.1%  
Return on capital %17.120.7 82.4%  
Exports to sales %8.339.4 21.0%   
Imports to sales %21.05.7 369.2%   
Exports (fob) Rs m8692,908 29.9%   
Imports (cif) Rs m2,209421 524.5%   
Fx inflow Rs m9593,445 27.8%   
Fx outflow Rs m2,612703 371.7%   
Net fx Rs m-1,6532,743 -60.3%   
CASH FLOW
From Operations Rs m1,0701,440 74.3%  
From Investments Rs m-750-1,089 68.8%  
From Financial Activity Rs m-150-353 42.5%  
Net Cashflow Rs m171-1 -11,469.8%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 51.8 1.5 3,523.8%  
Indian inst/Mut Fund % 18.2 7.8 232.1%  
FIIs % 1.0 16.6 6.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 26.0 111.9%  
Shareholders   28,591 25,395 112.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   FDC LTD.  UNICHEM LAB  WYETH LTD  AJANTA PHARMA  FULFORD INDIA  

Compare MERCK LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Lower; Realty & Auto Stocks Top Losers(09:30 am)

Asian shares eased in holiday-thinned trading on Monday and the safe haven yen gained as China canceled upcoming tariff talks with the United States.

Related Views on News

NATCO PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 93.3% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (up 93.3% YoY). Sales on the other hand came in at Rs 5 bn (up 21.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

MERCK LTD Announces Quarterly Results (1QFY19); Net Profit Up 63.1% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, MERCK LTD has posted a net profit of Rs 328 m (up 63.1% YoY). Sales on the other hand came in at Rs 2 bn (down 17.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Sep 24, 2018 01:25 PM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - UNICHEM LAB COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS